Interleukin 2 is produced by
**Core Concept**
Interleukin 2 (IL-2) is a type of cytokine, specifically a T cell growth factor, that plays a crucial role in the immune system. It is involved in the proliferation and differentiation of T lymphocytes, and is essential for the body's ability to mount an immune response.
**Why the Correct Answer is Right**
IL-2 is primarily produced by activated T cells, particularly CD4+ T helper cells and CD8+ cytotoxic T cells. When these T cells are stimulated by an antigen, they undergo activation and begin to produce IL-2, which in turn promotes the growth and proliferation of more T cells. This creates an autocrine loop that amplifies the immune response. The production of IL-2 is mediated by the transcription factor NF-AT (nuclear factor of activated T cells) and the enzyme CD28, which is a co-stimulatory receptor on the surface of T cells.
**Why Each Wrong Option is Incorrect**
**Option A:** Macrophages are a type of immune cell that play a role in the phagocytosis of pathogens, but they are not the primary producers of IL-2. While macrophages can produce some cytokines, they do not produce IL-2 in the same way that T cells do.
**Option B:** B cells are another type of immune cell that produce antibodies, but they are not typically associated with the production of IL-2. B cells can produce some cytokines, but their primary role is in the production of immunoglobulins.
**Option C:** Neutrophils are a type of white blood cell that play a role in the phagocytosis of pathogens, but they are not typically associated with the production of IL-2. Neutrophils are more involved in the acute inflammatory response than in the activation of T cells.
**Clinical Pearl / High-Yield Fact**
IL-2 has been used as a therapeutic agent in the treatment of certain types of cancer, such as melanoma and renal cell carcinoma, where it has been shown to stimulate the growth of T cells and enhance anti-tumor immunity. This has led to the development of IL-2-based immunotherapies, which are a promising area of research in the field of oncology.
**Correct Answer: C. Activated T cells, particularly CD4+ T helper cells and CD8+ cytotoxic T cells.